Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
Hehlmann
R
R
III. Medizinische Klinik, Klinikum Mannheim, Universität Heidelberg, Germany.
Ansari
H
H
Hasford
J
J
Heimpel
H
H
D002066:Busulfan / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D016019:Survival Analysis
D016898:Interferon-alpha; D002066:Busulfan; D006918:Hydroxyurea